D. Causey

Comparison of the Nicotine Pharmacokinetics of Nicoderm (Nicotine Transdermal System) and Half‐Hourly Cigarette Smoking

S. Gupta, S. Hwang, D. Causey, 1995, Journal of clinical pharmacology.

Progression of Coronary Atherosclerosis

D. Waters, R. Havel, G. Gosselin, 2005 .

Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. A randomized, placebo-controlled, double-blind study.

S. Rennard, J. Prendergast, D. Daughton, 1991, Archives of internal medicine.

Pressure control inverse ratio ventilation as a method to reduce peak inspiratory pressure and provide adequate ventilation and oxygenation.

D. Lain, S. Morris, R. Saulters, 1989, Chest.

Transdermal Nicotine for Smoking Cessation: Six-Month Results From Two Multicenter Controlled Clinical Trials

A. Biglan, D. Hatsukami, S. Rennard, 1991 .

A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis.

P Théroux, D. Waters, R. Havel, 1990, Circulation.

Right ventricular hypertrophy detected by echocardiography in patients with newly diagnosed obstructive sleep apnea.

E. Berman, R. Dibenedetto, L. Goodman, 1991, Chest.

[Effects of transdermal nicotine as an adjunct in smoking cessation therapy. A double-blind randomized study controlled with placebo].

J. Prendergast, D. Daughton, A. B. Thompson, 1992, Archivio Monaldi per le malattie del torace.